ScholarIQanswers from OpenAlex
Nuffield Health
InstitutionResearch output, impact & collaborations
Nuffield Health is a institution indexed in ScholarIQ from OpenAlex.
What is known about Nuffield Health?
ScholarIQrecord summary
Nuffield Health is a research organisation in Epsom, GB. OpenAlex records 4,572 works and 351,462 citations for it. 975 researchers list it as their most recent affiliation.
How many works does Nuffield Health have?
ScholarIQindexed works
Nuffield Health has 4,572 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nuffield Health have?
ScholarIQcitation count
Nuffield Health has 351,462 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Nuffield Health?
ScholarIQresearcher count
Nuffield Health has 975 researchers in the ScholarIQ index.
What is the average h-index at Nuffield Health?
ScholarIQavg h-index
Nuffield Health has an average h-index of 83.7 in OpenAlex.
What is the ROR of Nuffield Health?
ScholarIQror
The ROR for Nuffield Health is on the source record.
What is the OpenAlex record for Nuffield Health?
ScholarIQopenalex
The OpenAlex for Nuffield Health is on the source record.
Who are the most-cited researchers behind Nuffield Health?
ScholarIQtop researchers by citations
What are the most-cited papers on Nuffield Health?
ScholarIQmost cited works
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
Karl Swedberg, John Kjekshus
Options for keeping the food system within environmental limits
Marco Springmann, Michael Clark, Daniel Mason-D’Croz, Keith Wiebe, Benjamin Leon Bodirsky, Luis Lassaletta, W. de Vries, Sonja Vermeulen, Mario Herrero, Kimberly M. Carlson, Malin Jonell, Max Troell, Fabrice DeClerck, Line Gordon, Rami Zurayk, Peter Scarborough, Mike Rayner, Brent Loken, Jessica Fanzo, H. Charles J. Godfray, David Tilman, Johan Rockström, Walter C. Willett
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Kalevi Pyörälà, Terje R. Pedersen, John Kjekshus, Ole Færgeman, Anders Olsson, Guðmundur Þorgeirsson, The Scandinavian Simvastatin Survival Study (4S) Group
How much of the research on Nuffield Health is open access?
ScholarIQopen access share
33%OPEN ACCESS